Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Pain, Intractable × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Classical hematology 1

Conditions

Sarcoma 145 Glioblastoma 60 Gliosarcoma 59 Osteosarcoma 35 Brain Neoplasms 34 Neoplasms 32 Recurrence 30 Astrocytoma 30 Gastrointestinal Stromal Tumors 28 Melanoma 27 Bone Neoplasms 27 Precursor Cell Lymphoblastic Leukemia-Lymphoma 26 Breast Neoplasms 26 Oligodendroglioma 25 Neoplasm Metastasis 25 Lymphoma 25 Dendritic Cell Sarcoma, Interdigitating 25 Glioma 24 Central Nervous System Neoplasms 23 Burkitt Lymphoma 23 Colorectal Neoplasms 22 Sarcoma, Ewing 21 Neuroblastoma 19 Lymphoma, Large B-Cell, Diffuse 19 Stomach Neoplasms 18 Ovarian Neoplasms 18 Lymphoma, Non-Hodgkin 18 Leukemia 18 Leukemia, Myeloid, Acute 17 Rhabdomyosarcoma 16

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00381095 2021-01-20

COPE

Pfizer

Phase 4 Terminated

152 enrolled 14 charts

Bone Neoplasms, Neoplasms, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡